Clinical Practice: Prevention and Treatment of Peanut Allergy @NEJMgroup

Uploaded June 2026 | Updated September 2026, 1 week ago

Peanuts should be introduced at 4 to 6 months of age in infants at high risk for allergy and at approximately 6 months of age in other infants. For infants with peanut allergy, early immunotherapy is safer and more effective. 

Learn more in the Clinical Practice article “Prevention and Treatment of Peanut Allergy,” at NEJM.org.

#pediatrics #immunology #nejm

Clinical Practice: Prevention and Treatment of Peanut Allergy

Dr. Glaucomflecken Explains: Rituximab versus Ocrelizumab in Relapsing Multiple Sclerosis

Could a Low-Plastic Lifestyle Lower Plastic Levels in our Body?

Three Studies That Made Headlines in May

Dr. Glaucomflecken Explains: Intensive LDL Cholesterol Targeting in Atherosclerotic CVD (Ez-PAVE)

Clinical Problem-Solving: Too Much of a Good Thing

NEJM Clinician: Are PPIs Linked to COPD Flares?

Naomi T. Nkinsi, MD, MPH, on Racial Bias in Diagnosing Kidney Disease

Aaron Baugh, MD, on Race-Specific Equations for Lung Function

NEJM Interview: Lawrence Casalino on qualities of corporate organizations that could affect physi...